Financials

1349 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM operating, investing, and financing activities

1349 free cash flow for Q1 25 is 19.82 k HKD. For 2024, 1349 free cash flow was -62.28 M HKD and operating cash flow was -16.01 M HKD.

Q2 '12

Q3 '12

Q4 '12

Q1 '13

Q2 '13

Q3 '13

Q2 '14

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: HKD